Aldena Therapeutics and Empa Awarded InnoSuisse Funding to Advance STAR Particles as a Novel Drug Delivery Technology for Dermatology ...Middle East

News by : (PR Newswire) -
BOSTON, April 26, 2023 /PRNewswire/ -- Aldena Therapeutics Inc. (Aldena), a private biotech company pioneering siRNA-based therapies for dermatological indications, and Empa, the Swiss Federal research institute for materials science and technology, have been awarded a joint 600'000 CHF...

Read More Details
Finally We wish PressBee provided you with enough information of ( Aldena Therapeutics and Empa Awarded InnoSuisse Funding to Advance STAR Particles as a Novel Drug Delivery Technology for Dermatology )

Also on site :

Most Viewed News
جديد الاخبار